Journal of Clinical Anesthesia
Volume 12, Issue 1 , Pages 67-71 , February 2000

Complex regional pain syndrome (CRPS) with resistance to local anesthetic block: a case report

  • Farrokh R Maneksha, MD (Associate Professor of Clinical Anesthesiology)

      Affiliations

    • Department of Anesthesiology, Health Sciences Center,State University of New York at Stony Brook, Stony Brook, NY, USA
    • Corresponding Author InformationAddress correspondence to Dr. Maneksha at the Department of Anesthesiology, Health Sciences Center, Level 4, State University of New York at Stony Brook, Stony Brook, NY 11794-8480, USA
    • ,
  • Himayun Mirza, MD (Fellow)

      Affiliations

    • Department of Anesthesiology, Health Sciences Center,State University of New York at Stony Brook, Stony Brook, NY, USA
    • ,
  • Paul J Poppers, MD (Distinguished Professor Chairman of Anesthesiology)

      Affiliations

    • Department of Anesthesiology, Health Sciences Center,State University of New York at Stony Brook, Stony Brook, NY, USA

Received 24 June 1999 ,Revised 13 October 1999 ,Accepted 13 October 1999.

References 

  1. Wilder RT, Berde CB, Wolohan M, Vieyra MA, Masek BJ, Micheli LJ (Reflex sympathetic dystrophy in children). Clinical characteristics and follow-up of seventy patients. J Bone Joint Surg Am. 1992;74:910–919
  2. Ashwal S, Tomasi L, Neumann M, Schneider S. Reflex sympathetic dystrophy syndrome in children. Pediatr Neurol. 1988;4:38–42
  3. Ruggeri SB, Athreya BH, Doughty R, Gregg JR, Das MM. Reflex sympathetic dystrophy in children. Clin Orthop. 1982;163:225–230
  4. Walker SM, Cousins MJ. Complex regional pain syndromes, including “reflex sympathetic dystrophy” and “causalgia. ” Anaesth Intensive Care. 1997;25:113–125
  5. Bruehl S, Carlson CR. Predisposing psychological factors in the development of reflex sympathetic dystrophy. A review of the empirical evidence. Clin J Pain. 1992;8:287–299
  6. Bruehl S, Lubenow TR, Nath H, Ivankovich O. Validation of thermography in the diagnosis of reflex sympathetic dystrophy. Clin J Pain. 1996;12:316–325
  7. Mailis A, Meindok H, Papagapiou M, Pham D. Alterations of the three-phase bone scan after sympathectomy. Clin J Pain. 1994;10:146–155
  8. Olcott C 4th, Eltherington LG, Wilcosky BR, Shoor PM, Zimmerman JJ, Fogarty TJ: Reflex sympathetic dystrophy—the surgeon’s role in management. J Vasc Surg 1991;14:488–92;.
  9. Dzwierzynski WW, Sanger JR. Reflex sympathetic dystrophy. Hand Clin. 1994;10:29–44
  10. Baron R, Janig W. Pain syndromes with causal participation of the sympathetic nervous system. Anaesthesist. 1998;47:4–23
  11. Drummond PD, Finch PM, Gibbins I. Innervation of hyperalgesic skin in patients with complex regional pain syndrome. Clin J Pain. 1996;12:222–231
  12. Raja SN, Choi Y, Asano Y, Holmes C, Goldstein DS. Arteriovenous differences in plasma concentrations of catechols in rats with neuropathic pain. Anesthesiology. 1995;83:1001–1008
  13. Roberts WJ. A hypothesis on the physiological basis for causalgia and related pains. Pain. 1986;24:297–311
  14. Rogers JN, Valley MA. Reflex sympathetic dystrophy. Clin Podiatr Med Surg. 1994;11:73–83
  15. Wilder RT, Berde CB, Wolohan M, Vieyra MA, Masek BJ, Micheli LJ. Reflex sympathetic dystrophy in children. Clinical characteristics and follow-up of seventy patients. J Bone Joint Surg Am. 1992;74:910–919
  16. Gedalia A, Adar A, Kornmehl P. Reflex sympathetic dystrophy in children. Harefuah. 1990;119:197–198
  17. Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy [Letter]. J Pain Symptom Manage. 1995;10:265–266
  18. Mackin GA. Medical and pharmacologic management of upper extremity neuropathic pain syndromes. J Hand Ther. 1997;10:96–109
  19. Houtchens MK, Richert JR, Sami A, Rose JW. Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler. 1997;3:250–253
  20. McCaffery M. Gabapentin for lancinating neuropathic pain. Am J Nurs. 1998;98:12
  21. Linson MA, Leffert R, Todd DP. The treatment of upper extremity reflex sympathetic dystrophy with prolonged continuous stellate ganglion blockade. J Hand Surg Am. 1983;8:153–159
  22. Hoffman J, Phillips W, Blum M, Barohn R, Ramamurthy S. Effect of sympathetic block demonstrated by triple-phase bone scan. J Hand Surg Am. 1993;18:860–863
  23. Arden RL, Bahu SJ, Zuazu MA, Berguer R. Reflex sympathetic dystrophy of the face (current treatment recommendations). Laryngoscope. 1998;108:437–442
  24. Cooper DE, DeLee JC, Ramamurthy S. Reflex sympathetic dystrophy of the knee. Treatment using continuous epidural anesthesia. J Bone Joint Surg Am. 1989;71:365–369
  25. Sachs BL, Zindrick MR, Beasley RD. Reflex sympathetic dystrophy after operative procedures on the lumbar spine. J Bone Joint Surg Am. 1993;75:721–725
  26. Malik VK, Inchiosa MA, Mustafa K, Sanapati MR, Pimentel MC, Frost EA. Intravenous regional phenoxybenzamine in the treatment of reflex sympathetic dystrophy. Anesthesiology. 1998;88:823–827
  27. Benzon HT, Chomka CM, Brunner EA. Treatment of reflex sympathetic dystrophy with regional intravenous reserpine. Anesth Analg. 1980;59:500–502
  28. Blanchard J, Ramamurthy S, Walsh N, Hoffman J, Schoenfeld L. Intravenous regional sympatholysis (a double-blind comparison of guanethidine, reserpine, and normal saline). J Pain Symptom Manage. 1990;5:357–361
  29. Hord AH, Rooks MD, Stephens BO, Rogers HG, Fleming LL. Intravenous regional bretylium and lidocaine for treatment of reflex sympathetic dystrophy (a randomized, double-blind study). Anesth Analg. 1992;74:818–821
  30. Connelly NR, Reuben S, Brull SJ. Intravenous regional anesthesia with ketorolac-lidocaine for the management of sympathetically-mediated pain. Yale J Biol Med. 1995;68:95–99
  31. Farah BA. Ketorolac in reflex sympathetic dystrophy. Clin Neuropharmacol. 1993;16:88–89
  32. Nagaro T, Shimizu C, Inoue H, et al.  The efficacy of intravenous lidocaine on various types of neuropathic pain. Masui. 1995;44:862–867
  33. Chaplan SR, Bach FW, Shafer SL, Yaksh TL. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology. 1995;83:775–785
  34. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain. 1996;66:69–77
  35. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine (a prospective study). J Pain Symptom Manage. 1996;12:161–167
  36. Valley MA, Sheplock GJ, Rogers JN. Probable cervical midline epidural septum complicating the treatment of a patient with upper extremity sympathetically maintained pain. J Pain Symptom Manage. 1994;9:208–211
  37. Bonica JJ. In: Management of Pain, 2nd ed. Philadelphia: Lea & Febiger; 1990;p. 1956
  38. Wilder RT, Sholas MG, Berde CB. NG-nitro-L-arginine methyl ester (L-NAME) prevents tachyphylaxis to local anesthetics in a dose-dependent manner. Anesth Analg. 1996;83:1251–1255
  39. Lee KC, Wilder RT, Smith RL, Berde CB. Thermal hyperalgesia accelerates and MK-801 prevents the development of tachyphylaxis to rat sciatic nerve blockade. Anesthesiology. 1994;81:1284–1293
  40. Fassoulaki A, Drasner K, Eger EI. Is chronic ethanol consumption associated with tolerance to intrathecal lidocaine in the rat?. Anesth Analg. 1990;70:489–492
  41. Krystal JH, Petrakis IL, Webb E, et al.  Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry. 1998;55:354–360
  42. Weight FF, Aguayo LG, White G, Lovinger DM, Peoples RW. GABA- and glutamate-gated ion channels as molecular sites of alcohol and anesthetic action. Adv Biochem Psychopharmacol. 1992;47:335–347

PII: S0952-8180(99)00126-9

Journal of Clinical Anesthesia
Volume 12, Issue 1 , Pages 67-71 , February 2000

Article Tools